SPP1 and prostate cancer: In accordance, in a recent meta-analysis of over 228 publications, high tumor or plasma OPN levels correlated with decreased disease-free survival and overall survival in multiple tumor types, including lung cancer, breast cancer, prostate cancer, head and neck cancer and liver cancer [13].